サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1373934

糖尿病治療薬市場：治療タイプ別、疾患別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Diabetes Therapeutics Market, By Therapy Type, By Diseases, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 308 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
糖尿病治療薬市場：治療タイプ別、疾患別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年10月01日
発行: AnalystView Market Insights
ページ情報: 英文 308 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

糖尿病治療薬の市場規模は2022年に652億10万米ドルと評価され、2023年から2030年にかけてCAGR 5.9％で拡大しました。

さらに、継続的なモニタリング、患者教育、積極的な関与は、糖尿病治療の不可欠な側面です。これらの要素は、血糖コントロールを達成し、合併症のリスクを低減し、糖尿病患者の長期的な健康と幸福を育む上で極めて重要な役割を果たしています。

糖尿病治療薬市場-市場力学

世界の糖尿病有病率の上昇が市場需要を促進

1型糖尿病と2型糖尿病の罹患率の増加は、しばしば座りがちなライフスタイル、不健康な食生活、肥満などの要因に関連しており、効果的な治療薬に対する需要の高まりにつながっています。糖尿病と診断される患者数や合併症の増加は、世界中のヘルスケアシステムに大きな圧力をかけています。これに対応するため、製薬会社や研究者は、インスリン製剤の改良、革新的な経口薬、持続グルコースモニタリングや人工膵臓システムなどの最先端技術など、新規治療法の開発に力を注いでいます。糖尿病の蔓延に対処することは、ヘルスケアの最優先課題として浮上しています。

糖尿病治療薬市場-主な洞察

弊社の調査アナリストによる分析によると、糖尿病治療薬の世界市場は、2023年から2030年までの予測期間において、年間約5.9%の成長率が見込まれています。

糖尿病治療薬業界は、世界の糖尿病有病率の増加が主な要因となって、大幅な成長が見込まれています。

治療タイプ別では、2022年は経口抗糖尿病薬が圧倒的なシェアを占めています。

疾患別セグメンテーションでは、妊娠糖尿病が2022年の主要治療薬として浮上しました。

糖尿病治療薬市場-セグメンテーション分析：

糖尿病治療薬の世界市場は、治療タイプ、疾患、エンドユーザー、地域などの主要パラメータを中心に構成されています。

治療タイプのカテゴリーでは、市場は3つの主要セグメントに分類されます：経口糖尿病治療薬、注射糖尿病治療薬、その他です。注目すべきは、経口糖尿病治療薬の分野です。糖尿病治療薬の分野では、経口糖尿病治療薬の需要が大きいです。多くの場合、錠剤やタブレットの形で入手可能なこれらの薬剤は、2型糖尿病患者の血糖値を効果的に管理する上で重要な役割を果たしています。経口治療の要であり、血糖コントロールと合併症の軽減に貢献しています。

糖尿病治療薬市場-地理的洞察

糖尿病治療薬の市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカなど、さまざまな地域にまたがっており、各地域はさらに、事業活動を行っている国ごとに区分されています。

特筆すべきは、アジア太平洋地域における糖尿病治療薬の需要の大きさです。まず、同地域では、都市化、座りがちなライフスタイル、食生活の変化などを主な要因として、糖尿病有病率が急増しています。これらの要因が、アジア太平洋地域における効果的な糖尿病治療薬に対するニーズの高まりにつながっています。

糖尿病治療薬市場-競合情勢：

糖尿病治療薬市場は、大手製薬企業や新興バイオテクノロジー企業を筆頭に、ダイナミックな競合情勢が特徴です。ノボノルディスク、サノフィ、イーライリリーなど、インスリン分野の著名な競合企業は、幅広いインスリン治療薬、注射用GLP-1受容体作動薬、経口糖尿病治療薬を開発・提供することで重要な役割を果たしています。

さらに、デックスコムやメドトロニックのような機器メーカーも、持続グルコースモニタリングシステムやインスリン送達デバイスを提供することで、この競合環境に貢献しており、市場に革新的なソリューションを導入し、糖尿病患者が利用できる治療の選択肢を増やしています。

目次

第1章 糖尿病治療薬市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 糖尿病治療薬の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 糖尿病治療薬業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 糖尿病治療薬市場：COVID-19感染症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 糖尿病治療薬市場情勢

  • 糖尿病治療薬市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 糖尿病治療薬市場- 疾患別

  • 概要
    • 疾患別セグメントシェア分析
    • 1型糖尿病
    • 2型糖尿病
    • 妊娠糖尿病

第8章 糖尿病治療薬市場- 治療法の種類別

  • 概要
    • 治療タイプ別のセグメントシェア分析
    • 経口糖尿病治療薬
    • 注射可能な抗糖尿病薬
    • その他

第9章 糖尿病治療薬市場- エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 病院と診療所
    • ホームケア
    • その他

第10章 糖尿病治療薬市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 糖尿病治療薬業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Astrazeneca PLC
    • Boehringer Ingelheim GmbH
    • Eli Lilly and Company
    • GlaxoSmithKline PLC
    • Novartis AG
    • Novo Nordisk
    • Sanofi SA
    • Takeda Pharmaceutical Company Limited
    • Johnson and Johnson Md&D
    • Merck and Co. Inc.

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data Therapy Types
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Diabetes Therapeutics Market: Diseases Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Diseases
  • TABLE Global Diabetes Therapeutics Market, by Diseases 2018-2030 (USD Million)
  • TABLE Diabetes Therapeutics Market: Therapy Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapy Type
  • TABLE Global Diabetes Therapeutics Market, by Therapy Type 2018-2030 (USD Million)
  • TABLE Diabetes Therapeutics Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Diabetes Therapeutics Market, by End User 2018-2030 (USD Million)
  • TABLE Diabetes Therapeutics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Diabetes Therapeutics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Diabetes Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Diabetes Therapeutics Market, by Diseases, 2018-2030 (USD Million)
  • TABLE North America Diabetes Therapeutics Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE North America Diabetes Therapeutics Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Diabetes Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Diabetes Therapeutics Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Europe Diabetes Therapeutics Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE Europe Diabetes Therapeutics Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Diabetes Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Diabetes Therapeutics Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Asia Pacific Diabetes Therapeutics Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Diabetes Therapeutics Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Diabetes Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Diabetes Therapeutics Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Latin America Diabetes Therapeutics Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE Latin America Diabetes Therapeutics Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Diabetes Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Diabetes Therapeutics Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Diabetes Therapeutics Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Diabetes Therapeutics Market, by End User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Diabetes Therapeutics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Diseases segment market share analysis, 2022 & 2030
  • FIGURE Diseases segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Therapy Type segment market share analysis, 2022 & 2030
  • FIGURE Therapy Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End User segment market share analysis, 2022 & 2030
  • FIGURE End User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Diabetes Therapeutics Market share and leading players, 2022
  • FIGURE Europe Diabetes Therapeutics Market share and leading players, 2022
  • FIGURE Asia Pacific Diabetes Therapeutics Market share and leading players, 2022
  • FIGURE Latin America Diabetes Therapeutics Market share and leading players, 2022
  • FIGURE Middle East and Africa Diabetes Therapeutics Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Diabetes Therapeutics Market share analysis by country, 2022
  • FIGURE Germany Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Diabetes Therapeutics Market share analysis by country, 2022
  • FIGURE India Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Diabetes Therapeutics Market share analysis by country, 2022
  • FIGURE Brazil Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Diabetes Therapeutics Market share analysis by country, 2022
  • FIGURE Saudi Arabia Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Diabetes Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1798

REPORT HIGHLIGHT

Diabetes Therapeutics Market size was valued at USD 65,200.1 Million in 2022, expanding at a CAGR of 5.9 % from 2023 to 2030.

Diabetes therapies encompass a diverse range of medical strategies and interventions devised for the management of diabetes mellitus, a chronic metabolic disorder characterized by elevated blood sugar levels. These therapeutic approaches are aimed at aiding individuals with diabetes in regulating their blood glucose levels, preventing complications, and ultimately improving their overall quality of life. The spectrum of diabetes treatment options includes dietary and lifestyle modifications, as well as oral medications, injectable insulin, and various pharmacological interventions.

Moreover, continuous monitoring, patient education, and active involvement are integral aspects of diabetes therapies. These elements play a pivotal role in achieving glycemic control, reducing the risk of complications, and fostering the long-term health and well-being of individuals living with diabetes.

Diabetes Therapeutics Market- Market Dynamics

Global rise in diabetes prevalence propels market demand

The escalating incidence of both type 1 and type 2 diabetes, often associated with factors such as sedentary lifestyles, unhealthy dietary habits, and obesity, has led to an increasing demand for effective therapies. The mounting number of diabetes diagnoses and related complications is placing substantial pressure on healthcare systems worldwide. In response, pharmaceutical companies and researchers are driven to develop novel treatments, including improved insulin formulations, innovative oral medications, and cutting-edge technologies such as continuous glucose monitoring and artificial pancreas systems. Addressing the diabetes epidemic has emerged as a paramount healthcare priority.

Diabetes Therapeutics Market- Key Insights

Based on the analysis provided by our research analyst, the global market for Diabetes Therapeutics is anticipated to experience an annual growth rate of approximately 5.9% over the forecast period spanning from 2023 to 2030.

The Diabetes Therapeutics industry is poised for substantial growth, largely attributed to the global increase in the prevalence of diabetes.

In terms of Therapy Type segmentation, the year 2022 witnessed Oral Antidiabetics as the dominant category.

Regarding Diseases segmentation, Gestational diabetes emerged as the leading Therapy Type in 2022.

Diabetes Therapeutics Market- Segmentation Analysis:

The Global Diabetes Therapeutics Market is structured around key parameters, including Therapy Type, Diseases, End User, and Region.

Within the Therapy Type category, the market is categorized into three primary segments: Oral Antidiabetics, Injectable Antidiabetics, and Others. Notably, the Oral Antidiabetics sector assumes a dominant position within the market. There is significant demand for oral antidiabetics in the field of diabetes therapeutics. These medications, often available in the form of pills or tablets, play a vital role in helping individuals with type 2 diabetes manage their blood sugar levels effectively. They are a cornerstone of oral treatment, contributing to glucose control and the reduction of complications.

Diabetes Therapeutics Market- Geographical Insights

The market for diabetes therapeutics spans across various regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa, with each region further segmented by individual countries engaged in business activities.

Notably, there is a substantial demand for diabetes medications in the Asia-Pacific region, attributed to several converging factors. Firstly, the region is witnessing a surge in diabetes prevalence, primarily fueled by urbanization, sedentary lifestyles, and dietary shifts. These factors collectively contribute to the growing need for effective diabetes treatments in the Asia-Pacific region.

Diabetes Therapeutics Market- Competitive Landscape:

The diabetes medications market features a dynamic and competitive landscape, with major pharmaceutical giants and emerging biotech companies at the forefront. Prominent competitors in the insulin sector, including Novo Nordisk, Sanofi, and Eli Lilly, play a crucial role by developing and offering a wide range of insulin therapies, injectable GLP-1 receptor agonists, and oral diabetes medications.

Furthermore, device manufacturers like Dexcom and Medtronic contribute to this competitive environment by providing continuous glucose monitoring systems and insulin delivery devices, introducing innovative solutions to the market and enhancing the treatment options available to individuals living with diabetes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIABETES THERAPEUTICS MARKET KEY PLAYERS

  • Astrazeneca PLC
  • Boehringer Ingelheim GmbH
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Novartis AG
  • Novo Nordisk
  • Sanofi SA
  • Takeda Pharmaceutical Company Limited
  • Johnson and Johnson Md&D
  • Merck and Co. Inc.

GLOBAL DIABETES THERAPEUTICS MARKET, BY THERAPY TYPE

  • Oral Antidiabetics
  • Injectable Antidiabetics
  • Others

GLOBAL DIABETES THERAPEUTICS MARKET, BY DISEASES

  • Type 1 diabetes
  • Type 2 diabetes
  • Gestational diabetes

GLOBAL DIABETES THERAPEUTICS MARKET, BY END USER

  • Hospitals and Clinics
  • Homecare
  • others

GLOBAL DIABETES THERAPEUTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Diabetes Therapeutics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Diabetes Therapeutics Market Snippet by Diseases
    • 2.1.2. Diabetes Therapeutics Market Snippet by Therapy Type
    • 2.1.3. Diabetes Therapeutics Market Snippet by End User
    • 2.1.4. Diabetes Therapeutics Market Snippet by Country
    • 2.1.5. Diabetes Therapeutics Market Snippet by Region
  • 2.2. Competitive Insights

3. Diabetes Therapeutics Key Market Trends

  • 3.1. Diabetes Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Diabetes Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Diabetes Therapeutics Market Opportunities
  • 3.4. Diabetes Therapeutics Market Future Trends

4. Diabetes Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Diabetes Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Diabetes Therapeutics Market Landscape

  • 6.1. Diabetes Therapeutics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Diabetes Therapeutics Market - By Diseases

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Diseases, 2022 & 2030 (%)
    • 7.1.2. Type 1 diabetes
    • 7.1.3. Type 2 diabetes
    • 7.1.4. Gestational diabetes

8. Diabetes Therapeutics Market - By Therapy Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapy Type, 2022 & 2030 (%)
    • 8.1.2. Oral Antidiabetics
    • 8.1.3. Injectable Antidiabetics
    • 8.1.4. Others

9. Diabetes Therapeutics Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 9.1.2. Hospitals and Clinics
    • 9.1.3. Homecare
    • 9.1.4. others

10. Diabetes Therapeutics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Diabetes Therapeutics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Diabetes Therapeutics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Diabetes Therapeutics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Diabetes Therapeutics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Diabetes Therapeutics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Diabetes Therapeutics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Astrazeneca PLC
    • 11.2.2. Boehringer Ingelheim GmbH
    • 11.2.3. Eli Lilly and Company
    • 11.2.4. GlaxoSmithKline PLC
    • 11.2.5. Novartis AG
    • 11.2.6. Novo Nordisk
    • 11.2.7. Sanofi SA
    • 11.2.8. Takeda Pharmaceutical Company Limited
    • 11.2.9. Johnson and Johnson Md&D
    • 11.2.10. Merck and Co. Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us